RDHL
Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)
RDHL Filings
Filing Date
Form Description
Form Type
2025-12-01
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-01 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-26
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-26 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-11-26
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-26 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-04
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-04 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-22
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-22 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-21
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-21 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-21
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-21 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-10-20
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-20 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-06
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-10-06 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
